Controlled prospective study to evaluate the inpatient naturopathic fasting therapy in overweight and obese patients

Not Applicable

• Conditions: E66; I10; I11; E78; R63.2; F50.4; Obesity; Essential (primary) hypertension; Hypertensive heart disease; Disorders of lipoprotein metabolism and other lipidaemias

• Registration Number: DRKS00006343
• Lead Sponsor: Abt. für Naturheilkunde, Klinik Blankenstein

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2008-08-31
• Study Start: 2014-11-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Patients aged from 18 to 75 years, who were overweight (BMI 25-29.9 kg / m²) or obese (BMI = 30 kg / m²), wished to reduce body weight and who were prescribed fasting therapy or a weight reduction diet as a form of nutritional therapy and gave informed consent were included.

Exclusion Criteria

We excluded pregnant and lactating women and patients who participated in another study simultaneously or in an organized weight-reduction program or took a medicament against obesity. Further exclusion criteria were: condition after extensive bowel resection or bariatric treatment, inflammatory bowel disease, malignant neoplastic disease, postoperative nutritional deficit, hepatic or renal failure, insulin-dependent diabetes mellitus, not compensated hypothyroidism or hyperthyroidism, coronary heart disease or acute or chronic cardiac arrhythmia, eating disorders like anorexia nervosa, bulimia or binge-eating disorder, severe psychiatric disorders, addictive disorders and dementia.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective of the present study is the weight loss after 6 months of patients who received in-patient fasting treatment in comparison to those receiving a weight reduction diet. A mean difference of 3 kg between the treatment groups was considered clinically significant: A permanent reduction of 5% of the starting weight is considered a success and a general goal of therapy in both German and U.S. American guidelines.